Caremark Cares About Profits

October 23, 2009

As appeared in the Washington Times
Bruce T. Roberts, RPh
Executive Vice President and CEO
National Community Pharmacists Association 

To the Editor, 

Getting patients to stick with their medication therapy is indeed an enormous challenge with significant potential for reduced health care costs as more expensive treatments and procedures are avoided ("Some solutions already at hand," Oct. 18, 2009). The annual cost of misusing medication was recently estimated at $290 billion. Trusted and accessible, community pharmacists are the single greatest resource to increase patient adherence. 

CVS Caremark is part of the problem, its recent lip service notwithstanding. Since the union of CVS stores with the largest pharmacy benefit manager (Caremark), they've broken pre-merger promises and aggressively push patients away from their longtime pharmacists. 

Higher co-payments on patients choosing independents. Refusing to cover prescriptions that aren't filled through mail order. These and other CVS Caremark practices put profits before patients, sever patient-pharmacist partnerships and increase the likelihood that patients lapse in their medication therapy - pushing those $290 billion costs even higher. 

From, 

Bruce T. Roberts, RPh, National Community Pharmacists Association (NCPA) Executive Vice President and CEO 

The original article is available on the Washington Times Web site.

NCPA Media Contacts

Kevin Schweers
Senior Vice President, Public Affairs
703.838.2682

John Norton
Director, Public Relations
703.600.1174

NCPA new release rss feed NCPA News Release Feed
What is RSS?

Our Experts

B. Douglas Hoey, RPh, MBA
CEO

Mark Riley, PD
NCPA President

Donnie Calhoun, P.D.
Immediate Past NCPA President

Lonny Wilson DPh
NCPA Past President

Ask Your Family Pharmacist TM